DR. PETER G. STOCK, MD
Radiology at Parnassus Ave, San Francisco, CA
License number
California G68680
Category
Radiology
Type
Transplant Surgery
License number
California G68680
Category
Radiology
Type
Surgery
Address
Address
400 Parnassus Ave, San Francisco, CA 94143
Phone
(415) 353-1551
(415) 353-8974 (Fax)
(415) 353-8974 (Fax)
Personal information
See more information about PETER G. STOCK at radaris.comName
Address
Phone
80 Levant St, San Francisco, CA 94114
30 Reedland Woods Way, Bel Tiburon, CA 94920
23862 Poplar View Ct, Valencia, CA 91354
1610 Stoneside Dr, Hemet, CA 92545
25901 Adolfo Ct, Valencia, CA 91355
Organization information
See more information about PETER G. STOCK at bizstanding.comUcsf Liver Transplant - Peter G Stock MD
350 Parnassus Ave STE 805, San Francisco, CA 94117
Categories:
Clinics, General Surgeons, Hospitals
Site:
Phone:
(415) 353-1888 (Phone)
Professional information
Owner At Peter Stock Press, Inc.
Position:
Owner at PETER STOCK PRESS, Inc.
Location:
San Francisco Bay Area
Industry:
Printing
Work:
PETER STOCK PRESS, Inc.
since 1989
-
Owner
Education:
University of California, Berkeley 1974 - 1978
Bachelor of Science (BS), Psychology
Bachelor of Science (BS), Psychology
Peter Grant Stock, San Francisco CA
Specialties:
Surgery, Transplant Surgery, Nephrology
Work:
UCSF Department of Surgery
521 Parnassus Ave, San Francisco, CA 94143
521 Parnassus Ave, San Francisco, CA 94143
Education:
University of Illinois at Chicago (1982)
Noncleavable Fas Ligand
US Patent:
6451759, Sep 17, 2002
Filed:
Jan 14, 1998
Appl. No.:
09/006755
Inventors:
Sang-Mo Kang - San Francisco CA
Andries Erik Braat - The Hague, NL
Steinunn Baekkeskov - San Francisco CA
Peter G. Stock - San Francisco CA
Andries Erik Braat - The Hague, NL
Steinunn Baekkeskov - San Francisco CA
Peter G. Stock - San Francisco CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3819
US Classification:
514 2, 530350, 530351, 4353201, 435325, 4353651, 4352523, 43525411, 536 235, 536 231, 424450
Abstract:
This invention generally provides polypeptides comprising a noncleavable form of a Fas ligand and having a capacity to activate a Fas receptor-mediated pathway involved in cell death, pharmaceutical compositions of such polypeptides, nucleic acids encoding such polypeptides, and cell lines capable of expressing these nucleic acids. Also provided are therapeutic and prophylactic methods of using such polypeptides, compositions, and cells lines for treating patients suffering from disorders resulting from dysregulation or inappropriate stimulation of the Fas receptor-mediated pathway.